Correlation Between Pasithea Therapeutics and Pluri

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Pluri at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Pluri into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Pluri Inc, you can compare the effects of market volatilities on Pasithea Therapeutics and Pluri and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Pluri. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Pluri.

Diversification Opportunities for Pasithea Therapeutics and Pluri

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pasithea and Pluri is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Pluri Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pluri Inc and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Pluri. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pluri Inc has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Pluri go up and down completely randomly.

Pair Corralation between Pasithea Therapeutics and Pluri

Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to under-perform the Pluri. But the stock apears to be less risky and, when comparing its historical volatility, Pasithea Therapeutics Corp is 1.12 times less risky than Pluri. The stock trades about -0.06 of its potential returns per unit of risk. The Pluri Inc is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  432.00  in Pluri Inc on August 28, 2024 and sell it today you would earn a total of  95.00  from holding Pluri Inc or generate 21.99% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy47.62%
ValuesDaily Returns

Pasithea Therapeutics Corp  vs.  Pluri Inc

 Performance 
       Timeline  
Pasithea Therapeutics 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Pasithea Therapeutics Corp are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Pasithea Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Pluri Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pluri Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Pluri is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pasithea Therapeutics and Pluri Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pasithea Therapeutics and Pluri

The main advantage of trading using opposite Pasithea Therapeutics and Pluri positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Pluri can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pluri will offset losses from the drop in Pluri's long position.
The idea behind Pasithea Therapeutics Corp and Pluri Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Commodity Directory
Find actively traded commodities issued by global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital